Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Key value for chemical safety assessment

Additional information

A subacute 28 -day oral toxicity study according to EEC Directive 92/69/EEC, B.7 Repeated Dose (28 days) Toxicity (oral) was performed. DEMB was administered daily for 28 days by oral gavage to Wistar rats. One control group and three treated groups (5, 25, 125 mg/kg bw) were tested, each consisting of 5 males and 5 females. The following parameters were evaluated: clinical signs, body weight, food consumption, clinical pathology and macroscopy at termination, organ weights and histopathology on a selection of tissues. In the 5 mg/kg group, no treatment-related findings could be observed. The application of 25 mg/kg resulted in slightly low body weights in females and a Decrease in erythrocyte cell count, haemoglobin and haematocrit in females. In the highest dose-group of 125 mg/kg, all animals died or had to be killed for humane reasons. Based on these results, the NOAEL was set to 25 mg/kg bw resulting in the classification STOT rep Cat.2.

Justification for classification or non-classification

According to Annex VI of the EU Regulation (EC) N0. 1272/2008 (CLP) and Annex I of the EU directive 67/548/EEC, DEMB is

classified as STOT rep Cat. 2 and R48, respectively.